These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16189442)

  • 21. Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide.
    Chamberlain MC
    Arch Neurol; 1997 May; 54(5):554-8. PubMed ID: 9152112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
    Terasaki M; Bouffet E; Katsuki H; Fukushima S; Shigemori M
    Surg Neurol; 2008 Jan; 69(1):46-50. PubMed ID: 18054615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival.
    Mikami M; Komuro Y; Sakaiya N; Tei C; Kurahashi T; Komiyama S; Hirose T
    Gynecol Oncol; 2001 Oct; 83(1):149-52. PubMed ID: 11585429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors.
    Goldwein JW; Glauser TA; Packer RJ; Finlay JL; Sutton LN; Curran WJ; Laehy JM; Rorke LB; Schut L; D'Angio GJ
    Cancer; 1990 Aug; 66(3):557-63. PubMed ID: 2364367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
    Needle MN; Goldwein JW; Grass J; Cnaan A; Bergman I; Molloy P; Sutton L; Zhao H; Garvin JH; Phillips PC
    Cancer; 1997 Jul; 80(2):341-7. PubMed ID: 9217048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etoposide for recurrent spinal cord ependymoma.
    Chamberlain MC
    Neurology; 2002 Apr; 58(8):1310-1. PubMed ID: 11971113
    [No Abstract]   [Full Text] [Related]  

  • 28. Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas.
    Kano H; Yang HC; Kondziolka D; Niranjan A; Arai Y; Flickinger JC; Lunsford LD
    J Neurosurg Pediatr; 2010 Nov; 6(5):417-23. PubMed ID: 21039163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral etoposide for recurrent/progressive sarcomas of childhood.
    Kebudi R; Görgün O; Ayan I
    Pediatr Blood Cancer; 2004 Apr; 42(4):320-4. PubMed ID: 14966827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study.
    Grill J; Kalifa C; Doz F; Schoepfer C; Sainte-Rose C; Couanet D; Terrier-Lacombe MJ; Valteau-Couanet D; Hartmann O
    Pediatr Neurosurg; 1996 Jul; 25(1):7-12. PubMed ID: 9055328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
    Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
    Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study.
    Rose PG; Blessing JA; Soper JT; Barter JF
    Gynecol Oncol; 1998 Aug; 70(2):267-71. PubMed ID: 9740703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
    Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
    J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ependymal tumors in childhood.
    Agaoglu FY; Ayan I; Dizdar Y; Kebudi R; Gorgun O; Darendeliler E
    Pediatr Blood Cancer; 2005 Sep; 45(3):298-303. PubMed ID: 15770637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors.
    Pajtler KW; Tippelt S; Siegler N; Reichling S; Zimmermann M; Mikasch R; Bode U; Gnekow A; Pietsch T; Benesch M; Rutkowski S; Fleischhack G
    J Neurooncol; 2016 Jul; 128(3):463-71. PubMed ID: 27147083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
    Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors.
    Busca A; Miniero R; Besenzon L; Cordero di Montezemolo L; Cenni M; Fagioli F; Sandri A; Vassallo E; Ricardi U; Madon E
    Childs Nerv Syst; 1997; 13(11-12):572-7. PubMed ID: 9454971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.
    Geyer JR; Zeltzer PM; Boyett JM; Rorke LB; Stanley P; Albright AL; Wisoff JH; Milstein JM; Allen JC; Finlay JL
    J Clin Oncol; 1994 Aug; 12(8):1607-15. PubMed ID: 8040673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
    Finlay JL; Goldman S; Wong MC; Cairo M; Garvin J; August C; Cohen BH; Stanley P; Zimmerman RA; Bostrom B; Geyer JR; Harris RE; Sanders J; Yates AJ; Boyett JM; Packer RJ
    J Clin Oncol; 1996 Sep; 14(9):2495-503. PubMed ID: 8823328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.